RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer (Q42396417)
Jump to navigation
Jump to search
scientific article published on 4 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer |
scientific article published on 4 July 2016 |
Statements
1 reference
RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer (English)
1 reference
1 reference
Bryan T Hennessy
1 reference
Sinead Toomey
1 reference
Laura B Pritzker
1 reference
Ken P H Pritzker
1 reference
Anthony O'Grady
1 reference
Robert Cummins
1 reference
Liam Grogan
1 reference
John Kennedy
1 reference
Elaine W Kay
1 reference
Norma O'Donovan
1 reference
Roshni Kalachand
1 reference
John Crown
1 reference
1 reference
Identifiers
1 reference